http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 28 Jul 2026 08:00:43 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Nuwellis+installs+Aquadex+SmartFlow+systems+in+Wisconsin/26822708.html <p>Nuwellis, Inc. (Nasdaq: NUWE) has installed its Aquadex SmartFlow® ultrafiltration systems at a pediatric healthcare institution in Wisconsin, marking the company's first entry into that state's pediatric market, according to a press release.</p> <p>The installations are intended to support the development of clinical pathways and integrate Aquadex therapy into the hospital's pediatric care program. The institution was described only as a leading academic medical center in the region; Nuwellis did not identify it by name.</p> <p>"Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy," said CEO Mike McCormick.</p> <p>The http://www.streetinsider.com/Corporate+News/Nuwellis+installs+Aquadex+SmartFlow+systems+in+Wisconsin/26822708.html Tue, 28 Jul 2026 08:00:43 -0400 A.06822034 NUWE O.07042764 O.20026344 http://www.streetinsider.com/Corporate+News/Nuwellis+installs+Aquadex+SmartFlow+systems+in+Wisconsin/26822708.html <p>Nuwellis, Inc. (Nasdaq: NUWE) has installed its Aquadex SmartFlow® ultrafiltration systems at a pediatric healthcare institution in Wisconsin, marking the company's first entry into that state's pediatric market, according to a press release.</p> <p>The installations are intended to support the development of clinical pathways and integrate Aquadex therapy into the hospital's pediatric care program. The institution was described only as a leading academic medical center in the region; Nuwellis did not identify it by name.</p> <p>"Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy," said CEO Mike McCormick.</p> <p>The http://www.streetinsider.com/Corporate+News/Nuwellis+installs+Aquadex+SmartFlow+systems+in+Wisconsin/26822708.html Tue, 28 Jul 2026 08:00:43 -0400 A.06822034 NUWE O.07042764 O.20026344 http://www.streetinsider.com/Corporate+News/Nuwellis+installs+Aquadex+SmartFlow+systems+in+Wisconsin/26822708.html <p>Nuwellis, Inc. (Nasdaq: NUWE) has installed its Aquadex SmartFlow® ultrafiltration systems at a pediatric healthcare institution in Wisconsin, marking the company's first entry into that state's pediatric market, according to a press release.</p> <p>The installations are intended to support the development of clinical pathways and integrate Aquadex therapy into the hospital's pediatric care program. The institution was described only as a leading academic medical center in the region; Nuwellis did not identify it by name.</p> <p>"Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy," said CEO Mike McCormick.</p> <p>The http://www.streetinsider.com/Corporate+News/Nuwellis+installs+Aquadex+SmartFlow+systems+in+Wisconsin/26822708.html Tue, 28 Jul 2026 08:00:43 -0400 A.06822034 NUWE O.07042764 O.20026344 http://www.streetinsider.com/Corporate+News/Nuwellis+installs+Aquadex+SmartFlow+systems+in+Wisconsin/26822708.html <p>Nuwellis, Inc. (Nasdaq: NUWE) has installed its Aquadex SmartFlow® ultrafiltration systems at a pediatric healthcare institution in Wisconsin, marking the company's first entry into that state's pediatric market, according to a press release.</p> <p>The installations are intended to support the development of clinical pathways and integrate Aquadex therapy into the hospital's pediatric care program. The institution was described only as a leading academic medical center in the region; Nuwellis did not identify it by name.</p> <p>"Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy," said CEO Mike McCormick.</p> <p>The http://www.streetinsider.com/Corporate+News/Nuwellis+installs+Aquadex+SmartFlow+systems+in+Wisconsin/26822708.html Tue, 28 Jul 2026 08:00:43 -0400 A.06822034 NUWE O.07042764 O.20026344 http://www.streetinsider.com/Press+Releases/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html <p align="justify">MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its expansion into Wisconsin with the installation of its first Aquadex SmartFlow® systems at a leading pediatric healthcare institution. The installation further expands the Company&apos;s growing presence in pediatric critical care at one of the region&apos;s premier academic medical centers.</p> <p align="justify">&quot;Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy and entry into a key market facilitating http://www.streetinsider.com/Press+Releases/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html Tue, 28 Jul 2026 08:00:00 -0400 A.06822034 NUWE O.07042764 O.20026344 http://www.streetinsider.com/Press+Releases/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html <p align="justify">MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its expansion into Wisconsin with the installation of its first Aquadex SmartFlow® systems at a leading pediatric healthcare institution. The installation further expands the Company&apos;s growing presence in pediatric critical care at one of the region&apos;s premier academic medical centers.</p> <p align="justify">&quot;Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy and entry into a key market facilitating http://www.streetinsider.com/Press+Releases/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html Tue, 28 Jul 2026 08:00:00 -0400 A.06822034 NUWE O.07042764 O.20026344 http://www.streetinsider.com/Press+Releases/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html <p align="justify">MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its expansion into Wisconsin with the installation of its first Aquadex SmartFlow® systems at a leading pediatric healthcare institution. The installation further expands the Company&apos;s growing presence in pediatric critical care at one of the region&apos;s premier academic medical centers.</p> <p align="justify">&quot;Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy and entry into a key market facilitating http://www.streetinsider.com/Press+Releases/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html Tue, 28 Jul 2026 08:00:00 -0400 A.06822034 NUWE O.07042764 O.20026344 http://www.streetinsider.com/Press+Releases/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html <p align="justify">MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its expansion into Wisconsin with the installation of its first Aquadex SmartFlow® systems at a leading pediatric healthcare institution. The installation further expands the Company&apos;s growing presence in pediatric critical care at one of the region&apos;s premier academic medical centers.</p> <p align="justify">&quot;Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy and entry into a key market facilitating http://www.streetinsider.com/Press+Releases/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html Tue, 28 Jul 2026 08:00:00 -0400 A.06822034 NUWE O.07042764 O.20026344 http://www.streetinsider.com/Globe+Newswire/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html <p align="justify">MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its expansion into Wisconsin with the installation of its first Aquadex SmartFlow® systems at a leading pediatric healthcare institution. The installation further expands the Company&apos;s growing presence in pediatric critical care at one of the region&apos;s premier academic medical centers.</p> <p align="justify">&quot;Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy and entry into a key market facilitating http://www.streetinsider.com/Globe+Newswire/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html Tue, 28 Jul 2026 08:00:00 -0400 A.06822034 NUWE O.07042764 O.20026344 http://www.streetinsider.com/Globe+Newswire/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html <p align="justify">MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its expansion into Wisconsin with the installation of its first Aquadex SmartFlow® systems at a leading pediatric healthcare institution. The installation further expands the Company&apos;s growing presence in pediatric critical care at one of the region&apos;s premier academic medical centers.</p> <p align="justify">&quot;Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy and entry into a key market facilitating http://www.streetinsider.com/Globe+Newswire/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html Tue, 28 Jul 2026 08:00:00 -0400 A.06822034 NUWE O.07042764 O.20026344 http://www.streetinsider.com/Globe+Newswire/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html <p align="justify">MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its expansion into Wisconsin with the installation of its first Aquadex SmartFlow® systems at a leading pediatric healthcare institution. The installation further expands the Company&apos;s growing presence in pediatric critical care at one of the region&apos;s premier academic medical centers.</p> <p align="justify">&quot;Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy and entry into a key market facilitating http://www.streetinsider.com/Globe+Newswire/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html Tue, 28 Jul 2026 08:00:00 -0400 A.06822034 NUWE O.07042764 O.20026344 http://www.streetinsider.com/Globe+Newswire/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html <p align="justify">MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its expansion into Wisconsin with the installation of its first Aquadex SmartFlow® systems at a leading pediatric healthcare institution. The installation further expands the Company&apos;s growing presence in pediatric critical care at one of the region&apos;s premier academic medical centers.</p> <p align="justify">&quot;Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy and entry into a key market facilitating http://www.streetinsider.com/Globe+Newswire/Nuwellis+Expands+Pediatric+Footprint+with+First+Aquadex+SmartFlow%C2%AE+Installations+in+Wisconsin/26822681.html Tue, 28 Jul 2026 08:00:00 -0400 A.06822034 NUWE O.07042764 O.20026344 http://www.streetinsider.com/Guidance/Nuwellis+reports+preliminary+14%25+revenue+growth+in+Q2+2026/26816718.html <p>Nuwellis, Inc. (Nasdaq: NUWE) announced unaudited preliminary revenue results for its second quarter ended June 30, 2026, showing year-over-year growth of 14% for the quarter and 20% for the first half of 2026.</p><p>The Minneapolis-based medical technology company attributed the results to its Aquadex Ultrafiltration platform. The financial figures are unaudited and subject to adjustment as the company completes its quarterly review and finalizes financial statements for filing with its Form 10-Q.</p><p>"Revenue growth of 20% during the first half of 2026 demonstrates the increasing adoption of Aquadex and the progress we are making in executing our long-term growth strategy," said Mike http://www.streetinsider.com/Guidance/Nuwellis+reports+preliminary+14%25+revenue+growth+in+Q2+2026/26816718.html Mon, 27 Jul 2026 08:36:08 -0400 NUWE http://www.streetinsider.com/Corporate+News/Nuwellis+reports+preliminary+14%25+revenue+growth+in+Q2+2026/26816718.html <p>Nuwellis, Inc. (Nasdaq: NUWE) announced unaudited preliminary revenue results for its second quarter ended June 30, 2026, showing year-over-year growth of 14% for the quarter and 20% for the first half of 2026.</p><p>The Minneapolis-based medical technology company attributed the results to its Aquadex Ultrafiltration platform. The financial figures are unaudited and subject to adjustment as the company completes its quarterly review and finalizes financial statements for filing with its Form 10-Q.</p><p>"Revenue growth of 20% during the first half of 2026 demonstrates the increasing adoption of Aquadex and the progress we are making in executing our long-term growth strategy," said Mike http://www.streetinsider.com/Corporate+News/Nuwellis+reports+preliminary+14%25+revenue+growth+in+Q2+2026/26816718.html Mon, 27 Jul 2026 08:36:08 -0400 NUWE http://www.streetinsider.com/Press+Releases/Nuwellis+Announces+Preliminary+Revenue+Results+for+the+Second+Quarter+2026+Showing+Double+Digit+Growth/26816591.html <p align="center"><em>Company expects preliminary revenue year-over-year growth of 14% for second quarter 2026 and 20% for the first half of 2026 as Aquadex Ultrafiltration platform drives continued commercial momentum</em></p> <p align="center"><em>Nuwellis to report second quarter 2026 financial results on August 13</em></p> <p align="justify">MINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced unaudited preliminary results for its second quarter ended June 30, 2026, with revenue year-over-year growth of 14% for the second quarter of 2026 and 20% for the first http://www.streetinsider.com/Press+Releases/Nuwellis+Announces+Preliminary+Revenue+Results+for+the+Second+Quarter+2026+Showing+Double+Digit+Growth/26816591.html Mon, 27 Jul 2026 08:30:00 -0400 NUWE O.07042764 http://www.streetinsider.com/Press+Releases/Nuwellis+Announces+Preliminary+Revenue+Results+for+the+Second+Quarter+2026+Showing+Double+Digit+Growth/26816591.html <p align="center"><em>Company expects preliminary revenue year-over-year growth of 14% for second quarter 2026 and 20% for the first half of 2026 as Aquadex Ultrafiltration platform drives continued commercial momentum</em></p> <p align="center"><em>Nuwellis to report second quarter 2026 financial results on August 13</em></p> <p align="justify">MINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced unaudited preliminary results for its second quarter ended June 30, 2026, with revenue year-over-year growth of 14% for the second quarter of 2026 and 20% for the first http://www.streetinsider.com/Press+Releases/Nuwellis+Announces+Preliminary+Revenue+Results+for+the+Second+Quarter+2026+Showing+Double+Digit+Growth/26816591.html Mon, 27 Jul 2026 08:30:00 -0400 NUWE O.07042764 http://www.streetinsider.com/Globe+Newswire/Nuwellis+Announces+Preliminary+Revenue+Results+for+the+Second+Quarter+2026+Showing+Double+Digit+Growth/26816591.html <p align="center"><em>Company expects preliminary revenue year-over-year growth of 14% for second quarter 2026 and 20% for the first half of 2026 as Aquadex Ultrafiltration platform drives continued commercial momentum</em></p> <p align="center"><em>Nuwellis to report second quarter 2026 financial results on August 13</em></p> <p align="justify">MINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced unaudited preliminary results for its second quarter ended June 30, 2026, with revenue year-over-year growth of 14% for the second quarter of 2026 and 20% for the first http://www.streetinsider.com/Globe+Newswire/Nuwellis+Announces+Preliminary+Revenue+Results+for+the+Second+Quarter+2026+Showing+Double+Digit+Growth/26816591.html Mon, 27 Jul 2026 08:30:00 -0400 NUWE O.07042764 http://www.streetinsider.com/Globe+Newswire/Nuwellis+Announces+Preliminary+Revenue+Results+for+the+Second+Quarter+2026+Showing+Double+Digit+Growth/26816591.html <p align="center"><em>Company expects preliminary revenue year-over-year growth of 14% for second quarter 2026 and 20% for the first half of 2026 as Aquadex Ultrafiltration platform drives continued commercial momentum</em></p> <p align="center"><em>Nuwellis to report second quarter 2026 financial results on August 13</em></p> <p align="justify">MINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced unaudited preliminary results for its second quarter ended June 30, 2026, with revenue year-over-year growth of 14% for the second quarter of 2026 and 20% for the first http://www.streetinsider.com/Globe+Newswire/Nuwellis+Announces+Preliminary+Revenue+Results+for+the+Second+Quarter+2026+Showing+Double+Digit+Growth/26816591.html Mon, 27 Jul 2026 08:30:00 -0400 NUWE O.07042764 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuwellis%2C+Inc.++++++++++++For%3A+Jul+24/26813721.html si-local-file:///var/storage/secattach/20260724/26813721.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuwellis%2C+Inc.++++++++++++For%3A+Jul+24/26813721.html Fri, 24 Jul 2026 16:16:00 -0400 NUWE O.07042764 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuwellis%2C+Inc.++++++++++++For%3A+Jul+24/26813721.html si-local-file:///var/storage/secattach/20260724/26813721.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuwellis%2C+Inc.++++++++++++For%3A+Jul+24/26813721.html Fri, 24 Jul 2026 16:16:00 -0400 NUWE O.07042764 http://www.streetinsider.com/Corporate+News/Nuwellis+receives+U.S.+patent+for+dual+lumen+catheter+design/26777157.html <p>Nuwellis, Inc. (Nasdaq: NUWE) announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 12,678,592 on July 14, 2026, covering the company's Dual Lumen Catheter, a peripheral dual-lumen catheter designed for use with extracorporeal therapies including ultrafiltration, dialysis, and continuous renal replacement therapy.</p><p>The patented catheter incorporates a stainless-steel reinforcing coil intended to maintain catheter patency under negative pressure, which can cause catheter collapse during extracorporeal treatment. The design also allows clinicians to trim the catheter to a customized length for individual patients without compromising its structural integrity.</p><p>According to the company, the ability to customize catheter length while maintaining http://www.streetinsider.com/Corporate+News/Nuwellis+receives+U.S.+patent+for+dual+lumen+catheter+design/26777157.html Thu, 16 Jul 2026 08:33:09 -0400 NUWE http://www.streetinsider.com/Press+Releases/Nuwellis+Awarded+U.S.+Patent+for+Novel+Catheter+Technology+Designed+to+Enhance+Extracorporeal+Therapies/26777119.html <p>MINNEAPOLIS, July 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,678,592, covering the company’s Dual Lumen Catheter, a novel peripheral dual-lumen catheter designed for use with extracorporeal therapies, including ultrafiltration, dialysis, and continuous renal replacement therapy (CRRT) modalities. The patent was issued on July 14, 2026. It further expands Nuwellis&apos; intellectual property portfolio and supports the Company&apos;s broader strategy of advancing differentiated technologies across the heart-kidney continuum. Nuwellis continues to http://www.streetinsider.com/Press+Releases/Nuwellis+Awarded+U.S.+Patent+for+Novel+Catheter+Technology+Designed+to+Enhance+Extracorporeal+Therapies/26777119.html Thu, 16 Jul 2026 08:30:00 -0400 A.01908724 NUWE O.07042764 O.20988509 http://www.streetinsider.com/Press+Releases/Nuwellis+Awarded+U.S.+Patent+for+Novel+Catheter+Technology+Designed+to+Enhance+Extracorporeal+Therapies/26777119.html <p>MINNEAPOLIS, July 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,678,592, covering the company’s Dual Lumen Catheter, a novel peripheral dual-lumen catheter designed for use with extracorporeal therapies, including ultrafiltration, dialysis, and continuous renal replacement therapy (CRRT) modalities. The patent was issued on July 14, 2026. It further expands Nuwellis&apos; intellectual property portfolio and supports the Company&apos;s broader strategy of advancing differentiated technologies across the heart-kidney continuum. Nuwellis continues to http://www.streetinsider.com/Press+Releases/Nuwellis+Awarded+U.S.+Patent+for+Novel+Catheter+Technology+Designed+to+Enhance+Extracorporeal+Therapies/26777119.html Thu, 16 Jul 2026 08:30:00 -0400 A.01908724 NUWE O.07042764 O.20988509 http://www.streetinsider.com/Press+Releases/Nuwellis+Awarded+U.S.+Patent+for+Novel+Catheter+Technology+Designed+to+Enhance+Extracorporeal+Therapies/26777119.html <p>MINNEAPOLIS, July 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,678,592, covering the company’s Dual Lumen Catheter, a novel peripheral dual-lumen catheter designed for use with extracorporeal therapies, including ultrafiltration, dialysis, and continuous renal replacement therapy (CRRT) modalities. The patent was issued on July 14, 2026. It further expands Nuwellis&apos; intellectual property portfolio and supports the Company&apos;s broader strategy of advancing differentiated technologies across the heart-kidney continuum. Nuwellis continues to http://www.streetinsider.com/Press+Releases/Nuwellis+Awarded+U.S.+Patent+for+Novel+Catheter+Technology+Designed+to+Enhance+Extracorporeal+Therapies/26777119.html Thu, 16 Jul 2026 08:30:00 -0400 A.01908724 NUWE O.07042764 O.20988509 http://www.streetinsider.com/Press+Releases/Nuwellis+Awarded+U.S.+Patent+for+Novel+Catheter+Technology+Designed+to+Enhance+Extracorporeal+Therapies/26777119.html <p>MINNEAPOLIS, July 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,678,592, covering the company’s Dual Lumen Catheter, a novel peripheral dual-lumen catheter designed for use with extracorporeal therapies, including ultrafiltration, dialysis, and continuous renal replacement therapy (CRRT) modalities. The patent was issued on July 14, 2026. It further expands Nuwellis&apos; intellectual property portfolio and supports the Company&apos;s broader strategy of advancing differentiated technologies across the heart-kidney continuum. Nuwellis continues to http://www.streetinsider.com/Press+Releases/Nuwellis+Awarded+U.S.+Patent+for+Novel+Catheter+Technology+Designed+to+Enhance+Extracorporeal+Therapies/26777119.html Thu, 16 Jul 2026 08:30:00 -0400 A.01908724 NUWE O.07042764 O.20988509